Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |